Inventor
CAO JINGRONG
US37 patents
⚠️ This page may combine multiple inventors who share the name “CAO JINGRONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
29 patentsUS6784195B2Aug 31, 2004
Pyrazole compositions useful as inhibitors of ERK
VERTEX PHARMA182 citations99
US7084159B2Aug 1, 2006
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
VERTEX PHARMA104 citations98
US6642227B2Nov 4, 2003
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
VERTEX PHARMA109 citations98
US7253187B2Aug 7, 2007
Heterocyclic inhibitors of ERK2 and uses thereof
VERTEX PHARMA90 citations97
US6743791B2Jun 1, 2004
Heterocyclic inhibitors of ERK2 and uses thereof
VERTEX PHARMA123 citations97
US6699865B2Mar 2, 2004
Pyrazole compositions useful as inhibitors of ERK
VERTEX PHARMA71 citations97
US6593357B1Jul 15, 2003
Pyrazole compositions useful as inhibitors of ERK
VERTEX PHARMA81 citations97
US6495582B1Dec 17, 2002
Isoxazole compositions useful as inhibitors of ERK
VERTEX PHARMA104 citations97
US7056944B2Jun 6, 2006
Pyrazole compositions useful as inhibitors of erk
VERTEX PHARMA56 citations95
US8344153B2Jan 1, 2013
Inhibitors of phosphatidylinositol 3-kinase
VERTEX PHARMA47 citations94
US7514448B2Apr 7, 2009
Azaindoles useful as inhibitors of rock and other protein kinases
VERTEX PHARMA36 citations92
US6693108B2Feb 17, 2004
Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases
VERTEX PHARMA20 citations92
US6649640B2Nov 18, 2003
Isoxazole compositions useful as inhibitors of ERK
VERTEX PHARMA25 citations92
US7842686B2Nov 30, 2010
CGRP receptor antagonists
VERTEX PHARMA26 citations91
US8017781B2Sep 13, 2011
Azaindazoles useful as inhibitors of kinases
VERTEX PHARMA10 citations84
US7169798B2Jan 30, 2007
Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases
VERTEX PHARMA16 citations84
US9676759B2Jun 13, 2017
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
VERTEX PHARMA8 citations83
US11618746B2Apr 4, 2023
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA6 citations82
US11866446B2Jan 9, 2024
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA7 citations80
US7354919B2Apr 8, 2008
Isoxazole compositions useful as inhibitors of ERK
VERTEX PHARMA6 citations73
US10183933B2Jan 22, 2019
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
VERTEX PHARMA1 citations72
US12060346B2Aug 13, 2024
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA1 citations69
US10118904B2Nov 6, 2018
Triazoles for the treatment of Demyelinating Diseases
VERTEX PHARMA3 citations68
US7834000B2Nov 16, 2010
CGRP receptor antagonists
VERTEX PHARMA2 citations61
US12281102B2Apr 22, 2025
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA1 citations60
US12116343B2Oct 15, 2024
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA1 citations58
US12421249B2Sep 23, 2025
Inhibitors of APOL1 and methods of using same
VERTEX PHARMA0 citations57
US7612065B2Nov 3, 2009
Inhibitors of c-JUN N-terminal kinases (JNK)
VERTEX PHARMA1 citations49
US10766869B2Sep 8, 2020
Triazoles for the treatment of demyelinating dieases
VERTEX PHARMA0 citations48